Here are the five things you need to know, including the latest on Sarepta, possible changes at the FDA, real estate disputes, and the best time to be a soccer fan.

Sarepta Therapeutics Announces Leadership Change and Equity Deal November 26, 2024 — 07:48 am EST Written by TipRanks Auto-Generated Newsdesk for TipRanks -> ...

Sarepta Therapeutics recently report their Q4 and full-year 2022 earnings with a minor miss on EPS and a solid beat on revenue. Read more about SRPT here.

Reeling from the deaths of two patients who took Duchenne muscular dystrophy gene therapy Elevidys, Sarepta is launching a ...

Dyne Therapeutics stock crashed Tuesday after several key executives departed on the heels of what the company calls "unprecedented" in DMD.